Correlation of ADC With Pathological Treatment Response for Radiation Therapy of Pancreatic Cancer

Entesar Dalah, Beth Erickson, Kiyoko Oshima, Diane Schott, William A. Hall, Eric Paulson, An Tai, Paul Knechtges, X. Allen Li

Research output: Contribution to journalArticlepeer-review

36 Scopus citations


PURPOSE: To investigate the feasibility of using apparent diffusion coefficient (ADC) to assesspathological treatment response in pancreatic ductal adenocarcinoma (PDAC) following neoadjuvant chemoradiation (nCR). MATERIALS/METHODS: MRI and pathological data collected for 25patients with resectable and borderline resectable PDAC following nCR were retrospectively analyzed. Pre- and post-nCR mean ADC values in the tumors were compared using Wilcoxon matched pairs test. Correlation of pathological treatment response and ADC values was assessed using Pearson's correlation coefficient test and receiver-operating-curve (ROC) analysis. RESULTS: The average mean and standard deviation (SD) of the ADC values for all the patients analyzed were significantly higher in post-nCR (1.667±0.161×10-3) compared with those prior to nCR (1.395±0.136×10-3 mm2/sec), (P<0.05). The mean ADC values after nCR were significantly correlated with the pathological responses (r=-0.5172); P=0.02. The area under the curve (AUC) of the ADC values for differentiating G1, G2 and G3 pathological responses, using ROC analysis, was found to be 0.6310 and P=0.03. CONCLUSION: Changes of pre- and post-treatment ADC values significantly correlated with pathological treatment response for PDAC patients treated with chemoradiation therapy, indicating that the ADC could be used to assesstreatment response for PDAC.

Original languageEnglish (US)
Pages (from-to)391-398
Number of pages8
JournalTranslational Oncology
Issue number2
StatePublished - Apr 2018
Externally publishedYes

ASJC Scopus subject areas

  • Oncology
  • Cancer Research


Dive into the research topics of 'Correlation of ADC With Pathological Treatment Response for Radiation Therapy of Pancreatic Cancer'. Together they form a unique fingerprint.

Cite this